Drugs News and Research

RSS

New initiative to reduce prescription drug abuse

With overdoses and deaths involving the use of prescription drugs skyrocketing in the United States, the Department of Justice (DOJ) has selected the Heller School for Social Policy and Management at Brandeis University to host a new initiative to reduce diversion and abuse of these drugs: the PMP Center of Excellence.

26 Mar 2010

Altuglas International launches new acrylic resins for medical devices applications

Altuglas International, a world leader in acrylic plastics, has expanded its family of Medical grade acrylic resins, with Altuglas® CR30 and Altuglas® CR50 impactmodified grades. These resins, feature exceptional alcohols and lipids resistance that reduces environmental stress cracking due to attack of aggressive drugs and disinfectants. These novel acrylic resins are designed for easy injection molding of complex multi-cavity parts.

25 Mar 2010

New therapies increase survival rates in post-transplant liver cancer patients

A recent study found that sirolimus-based immunosuppression following liver transplantation in patients with non-resectable hepatocellular carcinoma (liver cancer) significantly increases survival rates for this patient population. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases (AASLD).

25 Mar 2010

Hepatitis C treatment less effective in urban minority patients

A recent study confirms that the standard hepatitis C (HCV) therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials. Results of this study appear in the April issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

25 Mar 2010

Senate starts debate clock on contentious health reform reconciliation bill

The Senate has begun debate, which Democrats hope to bring to a quick close, on a health care reform reconciliation bill that "fixes" parts of the law President Obama signed Tuesday.

25 Mar 2010

Techulon, UC sign worldwide exclusive license agreements to market Glycofect-Transfection Reagent

Techulon Inc., a life sciences company, has signed worldwide exclusive license agreements with the University of Cincinnati to manufacture and sell novel transfection reagents used for research and therapeutic delivery of nucleic acids.

25 Mar 2010

ScinoPharm announces record results for fiscal year 2009

ScinoPharm, an active pharmaceutical ingredient specialist, today announced audited record results for its fiscal year 2009. The company posted NT$3.791 billion in revenue, an increase of 20.54% over 2008.

25 Mar 2010

UNAIDS Executive Director calls for 'serious attention to TB' on World TB Day

In a statement marking World Tuberculosis Day, UNAIDS Executive Director Michel Sidibe "warned Wednesday that double infections of HIV and TB could become the next new epidemic," the Associated Press reports. Sidibe said, "I'm calling for serious attention to TB, and serious attention to TB-HIV co-infection" (Corder, 3/24).

25 Mar 2010

$Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports$

Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports

Osteoporosis is a disease of the bones usually affecting elderly women and causes the bones to become brittle and easily breakable. Since last two years some alarming reports of women on drugs for therapy of this disease have come to notice. These reports show that these drugs intended for therapy may result in rare and serious fractures of their thigh bones where the bones break clean or may splinter. Often these fractures were not associated with any fall or impact. Moreover some of the sufferers are middle aged women in their 50’s who do not have full blown osteoporosis, a condition known as pre-osteoporosis or osteopenia.

25 Mar 2010

Payers can improve risk-sharing approaches for expensive therapies and technology

Wolters Kluwer Pharma Solutions, Inc., a leading provider of scientific information and analytics to the pharmaceutical and biotech fields, announced today that it has published the collective recommendations of an international team of healthcare experts on how payers can improve their risk-sharing approaches for expensive new therapies and technology.

25 Mar 2010

Research could pave way for new generation of painkillers

An international group of scientists led by Dr Nikita Gamper of the University's Faculty of Biological Sciences has discovered how two proteins play a key role in the way we feel pain, offering new targets on which drug development can be focused.

25 Mar 2010

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.

25 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors (SSRIs), prescribed drugs that inhibit the effect of an important enzyme. Now researchers have developed a strategy for overcoming this problem, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today (Wednesday).

25 Mar 2010

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

The use of repetitive anesthesia with isoflurane (one of the most common anesthetics by inhalation) increases the risk of developing changes similar to those observed in AD brains in mice with mutations of the amyloid precursor protein (APP). This is the main conclusion of Spanish researchers coordinated by Doctors Maria -ngeles Mena and Justo Garc-a de Y-benes, from CIBERNED (Centro de Investigaci-n Biom-dica en Red de Enfermedades Neurodegenerativas).

25 Mar 2010

NIH grant for study on impact of gastric bypass surgery on Type II diabetes patients

Gastric bypass surgery, thought of by many as the last hope of morbidly obese people for losing weight, has many other benefits researchers are only beginning to understand.

25 Mar 2010

Health reform debate often misrepresents changes to Medicare

Seniors, as well as doctors who treat Medicare patients, "have been shaken up by news that health care reform efforts are largely funded by about $455 billion worth of projected savings in the government health insurance program for the elderly.

25 Mar 2010

China’s 3rd Annual Asia Scientific Congress programs feature latest updates on cancer

In an effort to curb the cancer rates, the country has adopted evidence-based treatment guidelines and continues to strengthen a number of strategic collaborations with the National Comprehensive Cancer Network® (NCCN®) as demonstrated by several NCCN programs scheduled throughout China this spring.

25 Mar 2010

Special medicated contact lenses can help treat common eye disorders

The popular dietary supplement vitamin E, loaded into special medicated contact lenses, can keep glaucoma medicine near the eye - where it can treat that common disease- almost 100 times longer than possible with current commercial lenses, scientists reported here today.

25 Mar 2010

DEA crackdown on nursing home drugs comes under Congressional scrutiny

The New York Times previews a Capitol Hill hearing Wednesday where nursing home operators and caregivers will criticize a narcotics crackdown by the Drug Enforcement Administration that they say "has left seriously ill patients crying for pain relief.

25 Mar 2010

DEA regulations will impact nursing home residents, says AAHSA

In written testimony to the U.S. Senate Special Committee on Aging as part of a hearing entitled, "The War on Drugs Meets the War on Pain: Nursing Home Residents Caught in the Crossfire," the American Association of Homes and Services for the Aging (AAHSA) urged the committee to support legislation designed to recognize "chart orders" and the functional role of nurses as the de facto agent of physicians whose patients reside in nursing facilities.

25 Mar 2010

Drugs News and Research

New initiative to reduce prescription drug abuse

Altuglas International launches new acrylic resins for medical devices applications

New therapies increase survival rates in post-transplant liver cancer patients

Hepatitis C treatment less effective in urban minority patients

Senate starts debate clock on contentious health reform reconciliation bill

Techulon, UC sign worldwide exclusive license agreements to market Glycofect-Transfection Reagent

ScinoPharm announces record results for fiscal year 2009

UNAIDS Executive Director calls for 'serious attention to TB' on World TB Day

Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports

Payers can improve risk-sharing approaches for expensive therapies and technology

Research could pave way for new generation of painkillers

Cardiologist receives grant to study impact of erectile dysfunction drugs on muscular dystrophy patients

Changing drug therapy can help breast cancer patients get full benefit of Tamoxifen

Anesthesia can increase behavioral changes, risk of developing Alzheimer's disease

NIH grant for study on impact of gastric bypass surgery on Type II diabetes patients

Health reform debate often misrepresents changes to Medicare

China’s 3rd Annual Asia Scientific Congress programs feature latest updates on cancer

Special medicated contact lenses can help treat common eye disorders

DEA crackdown on nursing home drugs comes under Congressional scrutiny

DEA regulations will impact nursing home residents, says AAHSA

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News